We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Wanna Be a Value Investor? Follow Buffett & Play 2 ETF Areas
Read MoreHide Full Article
Are you an ardent follower of investment guru Warren Buffett? Then you may find his latest bets to be intriguing investment areas.
Normally, Buffett takes interest in companies trading below what he believes is their intrinsic value. He aims long-term outperformance and apparently ignores short-term downturns. Probably this is why this investment veteran is now betting big on two value stocks, biotech giants Biogen (BIIB - Free Report) and retailer Kroger (KR - Free Report) . Both the stocks hold a top Value Score of A.
Notably, value investors like good stocks at great prices. The perception is that the lower the P/E or other valuation ratios like PEG or P/B, the higher will be the value of the stock. The logic behind this is that a stock’s current market price does not justify its higher expected earnings or book value and therefore has room to run.
Buffett Bets Big on Biotech Biggie Biogen
In a regulatory filing detailing its U.S.-listed investments as of Dec 31, Buffett’s Berkshire said it took a new 648,000-share stake in drug maker Biogen worth $192.4 million.
Biogen is one of the world’s leading biotechnology companies, which focuses on developing innovative therapies for treating serious neurological and neurodegenerative diseases. In late January, the company reported fourth-quarter results, wherein it beat on both the lines (read: Can Biotech ETFs Gain on Mixed Q4 Earnings Results?).
The stock beat earnings estimates in the past four quarters, the average being 9.33%. The stock currently has a Zacks Rank #3 (Hold) and belongs to a favorable Zacks industry (placed at the top 28% of 250+ industries).
Biogen has considerable exposure to ETFs like iShares Nasdaq Biotechnology ETF (IBB - Free Report) , VanEck Vectors Biotech ETF (BBH - Free Report) and iShares Evolved U.S. Innovative Healthcare ETF . IBB and BBH both have a Zacks Rank #2 (Buy) and make these funds a good proxy for Biogen investing. Notably, IBB, BBH and IEIH each has a P/E ratio of about 21x, slightly higher than the SPDR S&P 500 ETF TrustSPY’s 19.51x.
Retailer Kroger is Buffett’s Another Bet
Berkshire Hathaway also took position worth $549.1 million in Kroger Co. It is one of the nation’s largest grocery retailers. Further, it manufactures and processes certain food products that are sold in its supermarkets. The stock comes from a favorable Zacks industry (placed at the top 23% of 250+ industries) but it has a Zacks Rank #4 (Sell).
However, Kroger beat earnings expectations in the last two of four quarters, with the average positive surprise of 0.19%. If you are not satisfied with the earnings surprise history, you can bet on the Kroger-heavy ETF. This includes First Trust Nasdaq Retail ETF . The fund has a P/E ratio of17.77x (read: Retail ETFs Up on Q3 Earnings)..
Want key ETF info delivered straight to your inbox?
Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing ETFs, each week. Get it free >>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Wanna Be a Value Investor? Follow Buffett & Play 2 ETF Areas
Are you an ardent follower of investment guru Warren Buffett? Then you may find his latest bets to be intriguing investment areas.
Normally, Buffett takes interest in companies trading below what he believes is their intrinsic value. He aims long-term outperformance and apparently ignores short-term downturns. Probably this is why this investment veteran is now betting big on two value stocks, biotech giants Biogen (BIIB - Free Report) and retailer Kroger (KR - Free Report) . Both the stocks hold a top Value Score of A.
Notably, value investors like good stocks at great prices. The perception is that the lower the P/E or other valuation ratios like PEG or P/B, the higher will be the value of the stock. The logic behind this is that a stock’s current market price does not justify its higher expected earnings or book value and therefore has room to run.
Buffett Bets Big on Biotech Biggie Biogen
In a regulatory filing detailing its U.S.-listed investments as of Dec 31, Buffett’s Berkshire said it took a new 648,000-share stake in drug maker Biogen worth $192.4 million.
Biogen is one of the world’s leading biotechnology companies, which focuses on developing innovative therapies for treating serious neurological and neurodegenerative diseases. In late January, the company reported fourth-quarter results, wherein it beat on both the lines (read: Can Biotech ETFs Gain on Mixed Q4 Earnings Results?).
The stock beat earnings estimates in the past four quarters, the average being 9.33%. The stock currently has a Zacks Rank #3 (Hold) and belongs to a favorable Zacks industry (placed at the top 28% of 250+ industries).
Biogen has considerable exposure to ETFs like iShares Nasdaq Biotechnology ETF (IBB - Free Report) , VanEck Vectors Biotech ETF (BBH - Free Report) and iShares Evolved U.S. Innovative Healthcare ETF . IBB and BBH both have a Zacks Rank #2 (Buy) and make these funds a good proxy for Biogen investing. Notably, IBB, BBH and IEIH each has a P/E ratio of about 21x, slightly higher than the SPDR S&P 500 ETF Trust SPY’s 19.51x.
Retailer Kroger is Buffett’s Another Bet
Berkshire Hathaway also took position worth $549.1 million in Kroger Co. It is one of the nation’s largest grocery retailers. Further, it manufactures and processes certain food products that are sold in its supermarkets. The stock comes from a favorable Zacks industry (placed at the top 23% of 250+ industries) but it has a Zacks Rank #4 (Sell).
Kroger has invested heavily to expand online, refurbish stores and improve deliveries to compete with Walmart Inc (WMT - Free Report) and Amazon.com Inc (AMZN - Free Report) , per Reuters.
However, Kroger beat earnings expectations in the last two of four quarters, with the average positive surprise of 0.19%. If you are not satisfied with the earnings surprise history, you can bet on the Kroger-heavy ETF. This includes First Trust Nasdaq Retail ETF . The fund has a P/E ratio of17.77x (read: Retail ETFs Up on Q3 Earnings)..
Want key ETF info delivered straight to your inbox?
Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing ETFs, each week. Get it free >>